Jul 22, 2026 02:00PM
Jul 22, 2026 01:58PM
Jun 24, 2026 08:30AM
Jun 17, 2026 04:21PM
Jun 17, 2026 04:21PM
Jun 17, 2026 12:36PM
Jun 17, 2026 11:09AM GSK receives FDA approval for oral antibiotic to treat UTIs
Jun 9, 2026 09:44AM
Mar 19, 2026 08:22AM
Mar 19, 2026 08:13AM
Mar 13, 2026 11:46AM
Mar 13, 2026 11:44AM
Jan 12, 2026 06:15AM
Jan 12, 2026 06:15AM Summit Therapeutics Announces Clinical Trial Collaboration with GSK to Evaluate Ivonescimab in Combination with GSK’s B7-H3 Antibody Drug Conjugate (ADC)
Dec 17, 2025 04:40AM
Dec 16, 2025 09:55PM
Oct 30, 2025 07:27AM
Oct 24, 2025 05:24AM
Oct 23, 2025 08:11PM
Oct 21, 2025 02:00AM
Oct 21, 2025 02:00AM PIVOT-PO Phase 3 Data Show Tebipenem HBr’s Potential as the First Oral Carbapenem Antibiotic for Patients with Complicated Urinary Tract Infections (cUTIs)
Oct 17, 2025 07:01AM
Oct 17, 2025 07:00AM
Oct 1, 2025 10:00AM
Aug 29, 2025 12:08PM
Jul 23, 2025 12:08PM
Jul 17, 2025 07:01AM
Jul 17, 2025 07:00AM US FDA Approves GSK’s SHINGRIX in a Prefilled Syringe Presentation
Jul 10, 2025 09:13AM
Jul 10, 2025 09:13AM
Jun 24, 2025 09:02AM
Jun 24, 2025 09:00AM
Jun 2, 2025 06:20AM
Jun 2, 2025 06:00AM
May 28, 2025 07:01AM Spero Therapeutics (SPRO) and GSK (GSK) Announce PIVOT-PO Phase 3 Study for Tebipenem HBr Stopped Early for Efficacy
May 28, 2025 07:00AM
May 22, 2025 04:16PM
May 22, 2025 04:15PM
May 22, 2025 03:26PM
May 22, 2025 02:56PM
Apr 16, 2025 04:57PM
Apr 16, 2025 04:57PM GSK’s 5-in-1 Meningococcal Vaccine PENMENVY Receives Positive Recommendation from US Advisory Committee on Immunization Practices
Apr 9, 2025 05:00AM
Apr 6, 2025 08:33AM
Apr 4, 2025 01:04PM
Apr 1, 2025 02:41PM
Mar 31, 2025 08:59PM
Mar 31, 2025 04:00PM
Mar 31, 2025 02:35PM GSK DEADLINE: ROSEN, NATIONAL INVESTOR COUNSEL, Encourages GSK plc Investors to Secure Counsel Before Important April 7 Deadline in Securities Class Action - GSK
Mar 29, 2025 06:26PM

327,801 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All